Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron versus metoclopramide for hyperemesis gravidarum
IRCT20190528043735N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hyperemesis gravidarum (HG) comparing Ondansetron arm with Metoclopramide arm (2 arms). Primary endpoints: Nausea and vomiting severity, Number of drug doses and 1 more. Started Jun 2019; status: completed.
02
Drugs
ondansetronmetoclopramide
03
Conditions
hyperemesis gravidarum (HG)
Beyond the preview
Go deeper on IRCT20190528043735N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190528043735N1.